CA3189795A1 - Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementia - Google Patents
Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementiaInfo
- Publication number
- CA3189795A1 CA3189795A1 CA3189795A CA3189795A CA3189795A1 CA 3189795 A1 CA3189795 A1 CA 3189795A1 CA 3189795 A CA3189795 A CA 3189795A CA 3189795 A CA3189795 A CA 3189795A CA 3189795 A1 CA3189795 A1 CA 3189795A1
- Authority
- CA
- Canada
- Prior art keywords
- stimulation current
- current
- frequency
- series
- carrier waveform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Social Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD
FOR ALZHEIMERS AND DEMENTIA
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application relates to and claims the benefit of U.S.
Provisional Application No. 63/054,964 filed July 22, 2020 and entitled "TRANSCRANIAL
ALTERNATING CURRENT DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD FOR ALZHEIMERS AND DEMENTIA" the entire disclosure of which is hereby wholly incorporated by reference, and this application relates to and claims the benefit of U.S. Provisional Application No.
63/061,225, filed August 5, 2020 and entitled "TRANSCRANIAL ALTERNATING CURRENT
DYNAMIC FREQUENCY STIMULATION (TACS) SYSTEM AND METHOD
FOR ALZHEIMRS AND DEMENTIA" the entire disclosure of which is hereby wholly incorporated by reference.
STATEMENT RE: FEDERALLY SPONSORED RESEARCH/DEVELOPMENT
Conventional TCES devices, although employed for a number of different purposes, may have severe drawbacks. For example, many conventional TCES devices utilize a direct current (DC) component in order to break down or lower the resistance of the skin and to allow the treatment current (which may a combination of direct and alternating current) to penetrate to the nervous system.
therapies in which the levels of DC current are limited, these limited amounts of DC
current still often result in substantial user discomfort. Additionally, even when only an alternating current is applied to the skin, the layers of the skin generally result in a non-linear, complex impedance that invariably rectifies the AC signal and generates a DC component. This DC component depolarizes nociceptors in the skin, causing discomfort in the patient. If the DC-stimulated nociceptors are efferent to a trigeminal nerve branch in the head, the discomfort may be protected into the forehead region.
therapy.
Because of this upper limit on power, such conventional therapies are limited in their efficacy. This is especially pronounced when it may be desired to utilized TCES
therapy to treat Dementia diseases such as Alzheimer' s Dementia, where the amount of power delivered may be insufficient to penetrate into the deep structures in the brain associated with early Dementia and loss of memory and cognition.
BRIEF SUMMARY
stimulation current having a stimulation current envelope defining a series of pulses having a particular frequency, with the stimulation current being delivered for a particular duration, together designed to evoke particular metabolic responses in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation, especially those in which a direct current or a resultant rectified direct current component is administered to the patient. Further advantages, especially in promoting neural entrainment, may be realized as well via delivery of the charged-balanced stimulation current such that its envelope defines multiple series of pulses at different frequencies, and via the dynamic alteration of the stimulation current via incorporation of feedback signals in order to maintain charge balance in real-time, in order to maintain charge balance.
According to certain exemplary embodiments, the second series of pulse may occur at a frequency selected from:
about 4 Hz, about 40Hz, about 77.5 Hz.
According the particular refinements of such methods, the first series of pulses may occur at a frequency of about 40 Hz.
about 4 Hz, about 40Hz, about 77.5 Hz. Further, it is contemplated that the carrier waveform may have a frequency of about 100 KHz, may be a rectangular wave, or both.
BRIEF DESCRIPTION OF THE DRAWINGS
DETAILED DESCRIPTION
Duty Cycle Ratio Current Amplitude Ratio 1:3 2:1 1:4 3:1 1:5 4:1 Table 1: Charged Balanced Duty Cycle Ratio and Current Amplitude Ratio Pairings
When applied to the occipital region of the patient's brain, the stimulation current may induce neural entrainment, causing neurons within the patient's brain to be 10 stimulated an via polarization of the electrical charge on the outside of the membrane in accordance with the frequency of the first series of pulses. As long as the magnitude and pulse width of the pulses defined by the stimulation current envelope are sufficient to promote neural stimulation and trigger an action potential, and as long as the frequency of the series of pulses are not too high so as to permit the neuron to complete its refractory period prior to excitation via the subsequent pulse, neural entrainment may occur at the neurons that are affected by the stimulation current.
As may be seen, a higher magnitude pulse of a lesser pulse width may be sufficient to cause enough charge to accrue, or a lower magnitude pule of a greater pulse width may be sufficient, so long as the sufficient voltage is achieved at the membrane of the neuron as a result of delivery of the stimulation current. Further, it may be seen that so long as the frequency of the series of pulses are not too high (i.e., longer than the neuronal refractory period) each pulse will separate trigger another action potential within the neuron in order to cause natural entrainment to the frequency of the first series pulses.
It may further be seen, however, that configurations of the different parameters of stimulation currents may result in some pulses being received at some neurons prior to the recovery of the neuronal refractory period resulting from triggering of the action potential by an earlier pulse. Such schemes may be utilized in order to, for example, target entrainment of certain types or localities of neurons according to a first frequency, and to target entrainment of another type or locality of neurons according to a second frequency.
system may first digitally synthesize one or more high frequency rectangular AC
carrier waveforms, which may or may not be similar to the waveform illustrated in Fig. 1. The TCES system may then amplitude modulate the high frequency carrier waveform, as described in detail above, according to the particular parameters ultimately desired in the stimulation current, ultimately producing a stimulation current, which will then be conveyed to the patient. It is further contemplated that in certain embodiments, a measurement of electrode contact impedance may be taken at the patient at the point of delivery of the stimulation current via one or more reference electrodes. In these embodiments, the stimulation current may then be controlled (such as via alternation of the parameters of the high frequency carrier waveform, or by alteration of the various factors of the amplitude modulation) in order to better optimize the performance of the stimulation current, to confirm electrode contact quality, and to prevent any current imbalances that may result in unequal stimulation or inadvertent generation of DC components that may result in discomfort to the patient.
As may be seen, one exemplary embodiment of a TACS system may comprise a device chassis containing an AC/DC power supply, a stimulation circuitry printed circuit board (PCB), a front panel PCB, and a battery pack, configured for use with an external mains power source that feeds into the AC/DC power supply. Also included is a patient cable for conveying the stimulation current to the patient may be attached
system are to be understood as being purely for exemplary purposes in order to enable the reader to more fully understand the nature of the herein described systems and methods, and are not to be interpreted as representing or imposing any limitations of the subject matter described herein. For example, but without limitation, it may not be necessary for some or all components to be contained within a physical device chassis, or for many of these components to be present in the exact form described or at all.
[0045] The stimulation circuitry PCB may be for controlling the functionality of the TACS related to the generation and control of the stimulation current, including the synthesis of a high frequency carrier waveform. In this respect, it is to be understood as including as subsidiary components (which may be hardware or software components, or combinations thereof) both the waveform generator and the stimulation current generator. The stimulation circuitry PCB will be more fully described in relation to the foregoing discussion of Fig. 7.
system, and may include, for example, means for user input and for display of information to the user. The front panel PCB will be more fully described in relation to the foregoing discussion of Fig. 8.
battery management module, a power conditioning module, and inputs/outputs to the front panel PCB and to the patient cable. While this specific block diagram shows one exemplary version of the stimulation circuitry of a TACS system, it is certainly not the only configuration in which the systems and methods herein described may be achieved, and indeed, these descriptions of the physical and/or digital architecture of the stimulation circuitry of a TACS system are to be understood as being purely for exemplary purposes in order to enable the reader to more fully understand the nature of the herein described systems and methods, and are not to be interpreted as representing or imposing any limitations of the subject matter described herein. It is also to be understood that the respective modules described herein may be implemented in hardware, in software, or in combinations of hardware and software, including as subsidiary components of one another or integrated together.
system and its subordinate components in real time.
Following amplitude modulation of the carrier waveform, a digital to current source converter, i.e., the stimulation current generator, may be used to ultimately generate, from a digital representation of the amplitude modulated carrier waveform, the actual stimulation current for subsequent delivery to the patient.
According to a preferred embodiment, the stimulation current is about 15 mA.
However, it may be seen that the stimulation current flow may also be at different rates.
and to permit dynamic adjudgments to be made in real time to the stimulation current, such as via adjustment of the underlying waveform, the modulation signal(s), or directly at the stimulation current itself.
It is to be understood that a this description of a front panel is purely illustrative in nature and is specific to one exemplary embodiment of a TECS system, and that the presence, absence, or specific configuration of any front panel, or any panel located anywhere on any such device, or the controls or displays contained therein, are purely illustrative of merely one particular embodiment, and these descriptions are certainly not meant to impose any limitations on the inventive aspects of the herein described systems and methods.
Given the above disclosure, one skilled in the art could devise variations that are within the scope and spirit of the invention disclosed herein. Further, the various features of the embodiments disclosed herein can be used alone, or in varying combinations with each other and are not intended to be limited to the specific combination described herein. Thus, the scope of the claims is not to be limited by the exemplary embodiments.
Claims (25)
a carrier waveform generator;
a stimulation current generator, a stimulation current being generated from a carrier waveform output from the waveform generator, the carrier waveform being an alternating current having a duty cycle ratio and a current amplitude ratio, the duty cycle ratio and the current amplitude ratio being selected such that each respective pair of integrations of the current amplitude between successive time instances at which the carrier waveform alternates polarity is substantially equivalent; and a patient cable connectable to the stimulation current generator and to the patient, the stimulation current being conveyed to the patient via the patient cable.
about 4 Hz, about 40Hz, about 77.5 Hz.
(a) generating a stimulation current via the steps of:
generating a carrier waveform, the carrier waveform being an alternating current having a duty cycle ratio and a current amplitude ratio, the duty cycle ratio and the current amplitude ratio being selected such that each respective integration of the current amplitude between successive time instances at which the carrier waveform alternates polarity is substantially equivalent; and generating a stimulation current from the carrier waveform via amplitude modulating the carrier waveform, the extremes of the stimulation current defining a stimulation current envelope, the stimulation current envelope defining a first series of pulses occurring at a first frequency; and (b) Applying the stimulation current to the occipital region of the brain of the patient.
generating a carrier waveform, the carrier waveform being a rectangular alternating current having a first duty cycle ratio and a first current amplitude ratio, the first duty cycle ratio and the first current amplitude ratio being selected such that each respective integration of the current amplitude between successive time instances at which the waveform alternates polarity is substantially equivalent; and amplitude modulating the carrier waveform to derive a stimulation current, the extremes of the stimulation current defining a stimulation current envelope, the stimulation current envelope defining a first series of pulses occurring at a first frequency.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063054964P | 2020-07-22 | 2020-07-22 | |
| US63/054,964 | 2020-07-22 | ||
| US202063061225P | 2020-08-05 | 2020-08-05 | |
| US63/061,225 | 2020-08-05 | ||
| US17/116,233 | 2020-12-09 | ||
| US17/116,233 US11872397B2 (en) | 2020-07-22 | 2020-12-09 | Transcranial alternating current dynamic frequency stimulation (TACS) system |
| PCT/US2021/038084 WO2022020045A1 (en) | 2020-07-22 | 2021-06-18 | Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3189795A1 true CA3189795A1 (en) | 2022-01-27 |
Family
ID=79687670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3189795A Pending CA3189795A1 (en) | 2020-07-22 | 2021-06-18 | Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementia |
Country Status (3)
| Country | Link |
|---|---|
| CA (1) | CA3189795A1 (en) |
| MX (1) | MX2023000820A (en) |
| WO (1) | WO2022020045A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116919424B (en) * | 2023-08-24 | 2024-05-03 | 之江实验室 | Brain-computer interface rehabilitation device and electronic equipment |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6366813B1 (en) | 1998-08-05 | 2002-04-02 | Dilorenzo Daniel J. | Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease |
| US8190248B2 (en) * | 2003-10-16 | 2012-05-29 | Louisiana Tech University Foundation, Inc. | Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto |
| US9375571B2 (en) * | 2013-01-15 | 2016-06-28 | ElectroCore, LLC | Mobile phone using non-invasive nerve stimulation |
| US8583238B1 (en) * | 2012-10-02 | 2013-11-12 | Great Lakes Neuro Technologies Inc. | Wearable, unsupervised transcranial direct current stimulation (tDCS) device for movement disorder therapy, and method of using |
| EP3194014B1 (en) * | 2014-09-17 | 2020-04-15 | Neurolief Ltd. | Headset for neurostimulation and sensing of body parameters |
| US9750933B2 (en) * | 2014-12-18 | 2017-09-05 | Daniel T. Gregory | Transcutaneous neural stimulation device |
| HK1246713A1 (en) * | 2015-05-29 | 2018-09-14 | 赛威医疗公司 | Methods and apparatuses for transdermal electrical stimulation |
| CA3046937A1 (en) * | 2016-12-14 | 2018-06-21 | Inner Cosmos Llc | Brain computer interface systems and methods of use thereof |
| EP3840638A4 (en) * | 2018-08-23 | 2022-05-18 | The Regents Of The University Of California | NON-INVASIVE SPINAL CORD STIMULATION FOR NERVE ROOT PARALYSIS, CAUD'S TAIL SYNDROME AND RESTORATION OF UPPER LIMB FUNCTION |
-
2021
- 2021-06-18 CA CA3189795A patent/CA3189795A1/en active Pending
- 2021-06-18 MX MX2023000820A patent/MX2023000820A/en unknown
- 2021-06-18 WO PCT/US2021/038084 patent/WO2022020045A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| MX2023000820A (en) | 2023-04-24 |
| WO2022020045A1 (en) | 2022-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12011591B2 (en) | Transcranial alternating current dynamic frequency stimulation (TACS) method for Alzheimers and dementia | |
| US12285611B2 (en) | Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods | |
| EP3107622B1 (en) | Transcranial electrostimulation device | |
| US8265761B2 (en) | Cranial-electro stimulator | |
| US20060009820A1 (en) | Apparatus for the application of electrical pulses to the human body | |
| JP2008500086A (en) | Electrotherapy equipment | |
| US12263336B2 (en) | Alternating current dynamic frequency stimulation system and method for opioid use disorder (OUD) and substance use disorder (SUD) | |
| CA3189795A1 (en) | Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementia | |
| JP2003135607A (en) | Low frequency medical treating system | |
| US11944806B2 (en) | Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (ADI) | |
| WO2025037144A1 (en) | Method and multichanel device for non-invasive stimulation of vagus nerve | |
| HK40064029A (en) | Transcranial alternating current dynamic frequency stimulation (tacs) system and method for alzheimers and dementia | |
| US20250099756A1 (en) | Passive electrical neurofeedback treatment method for mild traumatic brain injury and post-concussion symptoms | |
| US20240189590A1 (en) | Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (adi) | |
| CA2707351C (en) | Improved cranial-electro stimulator |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20240510 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250415 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250523 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250523 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250815 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250818 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250929 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250929 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20260223 |